BASEC ID Project title Type of project Type of clinical trial Study phase (clinical trials only) multi- / monocentric Category Principal investigator Sponsor Investigational sites Lead EC Local EC(s) Approval date Minors Study Ended
2024-D0037 The DEXTER-assisted non-acute cholecystectomy Study clinical trial medical devices multicentric A1 Prof. Dr. med. Stefan Breitenstein Distalmotion SA Kantonsspital Winterthur, Winterthur
Hirslanden Zurich, Chirurgisches Zentrum Zürich
Witellikerstrasse 40
Kantonale Ethikkommission Zürich Kantonale Ethikkommission Zürich 14.06.2024
2024-D0011 BIOTRONIK – Safety and Clinical Performance of the Drug Eluting Resorbable Coronary MAGnesium Scaffold System (Freesolve®) in the Treatment of Subjects with de Novo Lesions in Native Coronary Arteries More ... clinical trial medical devices multicentric A2 PD Dr. med. BIOTRONIK AG Juan Fernando, Iglesias
Inselspital Bern, Bern
University Hospital Basel, University Heart Center
Petersgraben 4
Stadtspital Triemli, Klinik für Kardiologie
Birmensdorferstrasse 497
Universitätsspit More ...
Commission Cantonale d'éthique de la recherche Genève (CCER) Kantonale Ethikkommission Bern, Kantonale Ethikkommission Zürich, Ethikkommission Nordwest- und Zentralschweiz EKNZ 07.05.2024
2024-D0002 Clinical Performance Study Plan for FoundationOne® Liquid CDx as a Clinical Trial Assay in Clinical Trial GO42144 PLAN-00030, Version 04 clinical trial in vitro diagnostic medical devices multicentric C1 Dr. med. et phil. nat. Simon Häfliger Genentech, Inc. Inselspital Bern, Universitätsklinik für Medizinische Onkologie, Bern
Hôpitaux Universitaires de Genève, Département d'Oncologie, Rue Gabrielle-Perret-Gentil 4
Kantonale Ethikkommission Bern Commission Cantonale d'éthique de la recherche Genève (CCER) 27.03.2024 Study has ended
2024-00827 Is antisecretory therapy necessary after pancreatoduodenectomy and for how long? Factors influencing the outcome of pancreatic surgery patients - a two- centre project with 11 subprojects personal data/biological material multicentric Dr. med. Kristjan Ukegjin Department of General, Visceral, Endocrine and Transplant Surgery Department of General, Visceral, Endocrine and Transplant Surgery Kantonsspital St. Gallen, St. Gallen
Department of General, Visceral, Endocrine and Transplant Surgery Kantonsspital St. Gallen, St. G More ...
Ethikkommission Ostschweiz (EKOS) Ethikkommission Ostschweiz (EKOS), Kantonale Ethikkommission Zürich 20.06.2024
2024-00803 Development of a risk stratification score for recurrent venous thromboembolism and treatment-related clinically relevant bleeding in patients with cancer-associated thrombosis non clinical, involving persons multicentric A Dr. med. Kristina Vrotniakaite-Bajerciene Bern University Hospital Bern University Hospital, Bern
Geneva University Hospital, Geneva
Kantonale Ethikkommission Bern Commission Cantonale d'éthique de la recherche Genève (CCER) 18.06.2024
2024-00761 Solid cancer development in solid organ transplant recipients within the Swiss Transplant Cohort Study (2008-2022) personal data/biological material multicentric Dr. Eveline Daetwyler University Hospital Basel, Division of Medical Oncology Kantonsspital St. Gallen, St. Gallen
University Hospital Bern, Department for Nephrology and Hypertension, Bern
University Hospital Basel, Division of Medical Oncology, Basel
University Hospital Genev More ...
Ethikkommission Ostschweiz (EKOS) Ethikkommission Nordwest- und Zentralschweiz EKNZ, Kantonale Ethikkommission Bern, Kantonale Ethikkommission Zürich, Commission Cantonale d'éthique de la recherche Genève (CCER) 10.05.2024
2024-00736 A Swiss prospective multicenter longitudinal assessment of hypothalamic-pituitary-adrenal axis suppression after glucocorticoid therapy for leukemia and lymphoblastic lymphoma in children. An explorat More ... non clinical, involving persons multicentric A Professor Dr. med. Gabor Szinnai UKBB UKBB, Basel
Kinderspital Kantonsspital Aarau, Aarau
Ethikkommission Nordwest- und Zentralschweiz EKNZ Ethikkommission Nordwest- und Zentralschweiz EKNZ 30.05.2024 yes
2024-00728 Impact of beta blocker administration on outcome among patients undergoing transcatheter aortic valve replacement clinical trial other clinical trials multicentric A PD Dr. Thomas Nestelberger Universitätsspital Basel Universitätsspital Basel, Basel
Universitätsspital Inselspital Bern, Bern
Hopital Universitaire Genève, Genève
Universitätsspital Zürich, Zürich
Ethikkommission Nordwest- und Zentralschweiz EKNZ Kantonale Ethikkommission Bern, Kantonale Ethikkommission Zürich, Commission Cantonale d'éthique de la recherche Genève (CCER) 06.06.2024
2024-00721 Clinical Diagnostic Performance of the SpinChip high-sensitivity cardiac troponin I (SpinChip hs-cTnI) test non clinical, involving persons multicentric A MD, Professor Christian Muller SpinChip Diagnostics AS University Hospital Basel, Cardiovascular Research Institute Basel (CRIB) and Department of Cardiology, Basel
Luzerner Kantonsspital Clinic/Unitt, Chefarzt Notfallzentrum, Luzern
Ethikkommission Nordwest- und Zentralschweiz EKNZ Ethikkommission Nordwest- und Zentralschweiz EKNZ 03.06.2024
2024-00650 Intestinal biobank - A cross-sectional study of the mucosal microbiome of surgical and endoscopic tissue samples personal data/biological material multicentric Prof. Dr. med. Benjamin Misselwitz Inselspital Bern Inselspital, Universitätsklinik für Viszerale Chirurgie und Medizin, Bern
Pankreas Klinik Schweiz, Bern
Kantonale Ethikkommission Bern Kantonale Ethikkommission Bern 16.05.2024
2024-00621 Use of the national neonatal drug doses in Swiss children's hospitals personal data/biological material multicentric Dr. sc. Elisabeth Giger SwissPedDose SwissPedDose, Zürich
Kantonsspital Baden, Baden
Kantonsspital Aarau, Aarau
Hôpitaux Universitaires de Genève, Genf
Universitäts-Kinderspital Zürich, Zürich
Stadtspital Zürich Triemli, Zürich
Kantonssp More ...
Kantonale Ethikkommission Zürich Ethikkommission Nordwest- und Zentralschweiz EKNZ, Kantonale Ethikkommission Zürich, Commission Cantonale d'éthique de la recherche Genève (CCER) 25.06.2024
2024-00617 A Phase 3, Randomized, Open-label, Study to Compare the Efficacy and Safety of Adjuvant MK-2870 in Combination with Pembrolizumab (MK-3475) Versus Treatment of Physician’s Choice (TPC) in Participants More ... clinical trial drugs phase 3 multicentric C Dr. med. Urs Breitenstein MSD Merck Sharp & Dohme LLC Brustzentrum Zürich, Zürich
Spital Thun, Thun
Clinique Générale-Bealieu, Geneva
Hôpital cantonal Fribourg, Fribourg
Kantonsspital Graubünden, Graubünden
Kantonale Ethikkommission Zürich Kantonale Ethikkommission Bern, Kantonale Ethikkommission Zürich, Commission cantonale d'Éthique de la Recherche sur l'être humain Vaud (CER-VD), Commission Cantonale d'éthique de la recherche Genève More ... 25.06.2024
2024-00575 Natural behavior of pancreatic cystic neoplasms in immunosuppressed patients After Liver Transplantation (hALT IPMN) personal data/biological material multicentric PD Dr. med. Philip Müller University Hospital Basel University hospital Basel, Basel
Inselspital, Bauchzentrum Bern, Bern
Surgery Department Hôpital Universitaire Genève, Geneva
Unviversity Hospital Zürich, Zürich
Ethikkommission Nordwest- und Zentralschweiz EKNZ Kantonale Ethikkommission Bern, Kantonale Ethikkommission Zürich, Commission Cantonale d'éthique de la recherche Genève (CCER) 20.06.2024
2024-00573 Effect on Active Knee Joint Stabilization of a Specific-Targeted Sensorimotor Training Compared to Standard Care in Persons After ACL Reconstruction - A Randomised Controlled Trial clinical trial other clinical trials multicentric A Heiner Baur Berner Fachhochschule, Gesundheit, Physiotherapie Berner Fachhochschule, Gesundheit, Physiotherapie, Bern
Physio Aemme, Lützelflüh
chraftruum gmbh, Bern
Kantonale Ethikkommission Bern Kantonale Ethikkommission Bern 22.05.2024
2024-00572 Cytomegalovirus (CMV) replication under Letermovir as primary or secondary prophylaxis- a retrospective study UKBB-USB personal data/biological material multicentric Dr. med. Tamara Diesch-Furlanetto UKBB UKBB, Basel
Universitätsspital Basel, Basel
Ethikkommission Nordwest- und Zentralschweiz EKNZ Ethikkommission Nordwest- und Zentralschweiz EKNZ 03.05.2024
2024-00554 Eccentric Cycling Exercise during pulmonary rehabilitation in pulmonary vascular disease. clinical trial other clinical trials multicentric A Prof. Silvia Ulrich Universitätsspital Zürich University Hospital Zurich, Zürich
Klink Barmelweid, Barmelweid
Kantonale Ethikkommission Zürich Ethikkommission Nordwest- und Zentralschweiz EKNZ 29.05.2024
2024-00542 Elacestrant for treating ER+/HER2- breast cancer patients with ctDNA relapse clinical trial drugs phase 3 multicentric C Prof. Dr. med. Mathias Fehr European Organisation For Research And Treatment Of Cancer (EORTC) Spital Thurgau, Frauenfeld
Praxis Dr. Thorn / Praxis Onkologie Basel, Basel
Bürgerspital Solothurn, Solothurn
Ethikkommission Ostschweiz (EKOS) Ethikkommission Nordwest- und Zentralschweiz EKNZ 16.05.2024
2024-00540 Incidence of Mycoplasma pneumoniae infection in hospitalized children with Trisomy 21 – a 15 year retrospective study personal data/biological material multicentric PD. Dr. med. Philipp Agyeman Inselspital, Bern University Hospital Department of Pediatrics, Inselspital, Bern University Hospital, University of Bern, Bern
University Children's Hospital Zurich - Eleonorenstiftung, Zurich
Kantonale Ethikkommission Bern Kantonale Ethikkommission Zürich 28.05.2024
2024-00499 CAIN457A02001B - An open-label, multi-center protocol for patients who have completed a previous Novartis sponsored Secukinumab study and are judged by the investigator to benefit from continued Secuk More ... clinical trial drugs phase 4 multicentric C Prof. Dr. med. Thomas Daikeler Novartis Pharma Schweiz AG Universitätsspital Basel, Basel
Inselspital Bern - Universitätsspital, Bern
Kantonsspital St. Gallen, St. Gallen
Ethikkommission Nordwest- und Zentralschweiz EKNZ Ethikkommission Ostschweiz (EKOS), Kantonale Ethikkommission Bern 28.05.2024
2024-00470 A first-in-human, open-label, multicenter Phase I/II study to evaluate the safety and anti-tumor activity of ANV600 as single agent and in combination with pembrolizumab in participants with advanced More ... clinical trial drugs phase 1/2 multicentric C Prof. Dr. Dr. Markus Jörger Anaveon AG Kantonsspital St. Gallen, St. Gallen
Ente Ospedaliero Cantonale (EOC), Bellinzona
Ethikkommission Ostschweiz (EKOS) Comitato etico cantonale Ticino 25.04.2024